Gallic acid-based small-molecule inhibitors of JC and BK polyomaviral infection

Virus Research

Volumn 189, Issue , 2014, Pages 280-285

  O'Hara, Bethany A ^a   Rupasinghe, Chamila ^b   Yatawara, Achani ^b   Gaidos, Gabriel ^b   Mierke, Dale F ^b   Atwood, Walter J ^a  

^a BROWN UNIVERSITY   (United States)

^b Lamont Doherty Earth Observatory   (United States)

Author keywords

BKPyV; Hemorrhagic cystitis; JCPyV; Polyomavirus nephropathy; Progressive multifocal leukoencephalopathy; Virus receptors

Indexed keywords

ACETOBROMOALPHA GALACTOSE; CELL SURFACE RECEPTOR; ELLAGIC ACID; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GALACTOSE; GALLIC ACID; GLYCAN; PENTASACCHARIDE; SEROTONIN RECEPTOR; SHIKIMIC ACID; SIALIC ACID; TANNIN; UNCLASSIFIED DRUG; VIRUS RECEPTOR; ANTIVIRUS AGENT;

ANIMAL CELL; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; EMBRYO; FLOW CYTOMETRY; HEMORRHAGIC CYSTITIS; HUMAN; HUMAN CELL; KIDNEY CELL; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; POLYOMA VIRUS; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; VERO CELL LINE; VIRION; VIRUS ATTACHMENT; VIRUS INHIBITION; BK VIRUS; CELL LINE; DRUG EFFECTS; DRUG SCREENING; ISOLATION AND PURIFICATION; JC VIRUS;

ANTIVIRAL AGENTS; BK VIRUS; CELL LINE; DRUG EVALUATION, PRECLINICAL; GALLIC ACID; HUMANS; JC VIRUS; VIRUS ATTACHMENT;

EID: 84905997041     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.06.008     Document Type: Article

References (34)

1. Aksamit A.J. Progressive multifocal leukoencephalopathy. Curr. Treat. Options Neurol. 2008, 10:178-185.
2. Assetta B., Maginnis M.S., Gracia Ahufinger I., Haley S.A., Gee G.V., Nelson C.D., O'Hara B.A., Allen Ramdial S.A., Atwood W.J. 5-Ht2 receptors facilitate Jc polyomavirus entry. J. Virol. 2013, 87:13,490-13,498.
3. Bedi A., Miller C.B., Hanson J.L., Goodman S., Ambinder R.F., Charache P., Arthur R.R., Jones R.J. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J. Clin. Oncol. 1995, 13:1103-1109.
4. Berger J.R. The clinical features of PML. Cleve Clin. J. Med. 2011, 78(Suppl. 2):S8-S12.
5. Berger J.R., Clifford D.B. The manifold faces of PML and the challenge of diagnosis. Neurology 2011, 77:2006-2007.
6. Bloomgren G., Richman S., Hotermans C., Subramanyam M., Goelz S., Natarajan A., Lee S., Plavina T., Scanlon J.V., Sandrock A., Bozic C. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N. Engl. J. Med. 2012, 366:1870-1880.
7. Drachenberg C.B., Hirsch H.H., Papadimitriou J.C., Gosert R., Wali R.K., Munivenkatappa R., Nogueira J., Cangro C.B., Haririan A., Mendley S., Ramos E. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation 2007, 84:323-330.
8. Ferenczy M.W., Marshall L.J., Nelson C.D., Atwood W.J., Nath A., Khalili K., Major E.O. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin. Microbiol. Rev. 2012, 25:471-506.
9. Fonseca-Elphick G., Querbes W., Jordan J.A., Gee G.V., Eash S., Manley K., Dugan A., Stanifer M., Bhatnagar A., Kroeze W.K., Roth B.L., Atwood W.J. The human polyomavirus JCV, uses serotonin receptors to infect cells. Science 2004, 306:1241-1420.
10. Gee G.V., O'Hara B.A., Derdowski A., Atwood W.J. Pseudovirus mimics cell entry and trafficking of the human polyomavirus JCPyV. Virus Res. 2013, 178:281-286.
11. Hellwig K., Gold R. Progressive multifocal leukoencephalopathy and natalizumab. J. Neurol. 2011, 258:1920-1928.
12. Hirsch H.H. BK virus: opportunity makes a pathogen. Clin. Infect. Dis. 2005, 41:354-360.
13. Hirsch H.H., Knowles W., Dickenmann M., Passweg J., Klimkait T., Mihatsch M.J., Steiger J. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N. Engl. J. Med. 2002, 347:488-496.
14. Hirsch H.H., Steiger J. Polyomavirus BK. Lancet Infect. Dis. 2003, 3:611-623.
15. Kean J.M., Rao S., Wang M., Garcea R.L. Seroepidemiology of human polyomaviruses. PLoS Pathog. 2009, 5:e1000363.
16. Knowles W.A. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Adv. Exp. Med. Biol. 2006, 577:19-45.
17. Knowles W.A., Pipkin P., Andrews N., Vyse A., Minor P., Brown D.W., Miller E. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J. Med. Virol. 2003, 71:115-123.
18. Low J.A., Magnuson B., Tsai B., Imperiale M.J. Identification of gangliosides GD1b and GT1b as receptors for BK virus. J. Virol. 2006, 80:1361-1366.
19. Maginnis M.S., Haley S.A., Gee G.V., Atwood W.J. Role of N-linked glycosylation of the 5-HT2A receptor in JC virus infection. J. Virol. 2010, 84:9677-9684.
20. Major E.O., Miller A.E., Mourrain P., Traub R.G., de Widt E., Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:1257-1261.
21. Nelson C.D., Derdowski A., Maginnis M.S., O'Hara B.A., Atwood W.J. The VP1 subunit of JC polyomavirus recapitulates early events in viral trafficking and is a novel tool to study polyomavirus entry. Virology 2012, 428:30-40.
22. Neu U., Allen S.A., Blaum B.S., Liu Y., Frank M., Palma A.S., Stroh L.J., Feizi T., Peters T., Atwood W.J., Stehle T. A structure-guided mutation in the major capsid protein retargets BK polyomavirus. PLoS Pathog. 2013, 9:e1003688.
23. Neu U., Maginnis M.S., Palma A.S., Ströh L., Feizi T., Atwood W.J., Stehle T. Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif. Cell Host Microbe 2010, 8:309-319.
24. Neu U., Maginnis M.S., Palma A.S., Stroh L.J., Nelson C.D., Feizi T., Atwood W.J., Stehle T. Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif. Cell Host Microbe 2010, 8:309-319.
25. Ramos E., Drachenberg C.B., Papadimitriou J.C., Hamze O., Fink J.C., Klassen D.K., Drachenberg R.C., Wiland A., Wali R., Cangro C.B., Schweitzer E., Bartlett S.T., Weir M.R. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J. Am. Soc. Nephrol. 2002, 13:2145-2151.
26. Salunke D.M., Caspar D.L.D., Garcea R.L. Self assembly of purified polyomavirus capsid protein VP1. Cell 1986, 46:895-904.
27. Schaub S., Hirsch H.H., Dickenmann M., Steiger J., Mihatsch M.J., Hopfer H., Mayr M. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am. J. Transplant. 2010, 10:2615-2623.
28. Simpson D.M. HIV-associated PML: changing epidemiology and clinical approach. Cleve Clin. J. Med. 2011, 78(Suppl. 2):S24-S27.
29. Stehle T., Gamblin S.J., Yan Y., Harrison S.C. The structure of simian virus 40 refined at 3.1Å resolution. Structure 1996, 4:165-182.
30. Stehle T., Harrison S.C. Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. Structure 1996, 4:183-194.
31. Stehle T., Harrison S.C. High-resolution structure of a polyomavirus VP1-oligosaccharide complex: implications for assembly and receptor binding. EMBO J. 1997, 16:5139-5148.
32. Stehle T., Yan Y., Benjamin T.L., Harrison S.C. Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 1994, 369:160-163.
33. Tsai B., Gilbert J.M., Stehle T., Lencer W., Benjamin T.L., Rapoport T.A. Gangliosides are receptors for murine polyomavirus and SV40. EMBO J. 2003, 22:4346-4355.
34. Xie Y., Han Y., Wu D.P., Sun A.N., Cen J.N., Yao L., Ruan C.G. The BK virus load in urine in association with the development of hemorrhagic cystitis after hematopoietic stem cell transplantation. Zhonghua Xue Ye Xue Za Zhi 2009, 30:524-527.